About Shanghai Kaibao Pharmaceutical Company

The company was founded in 2000 and is mainly engaged in R&D, production and sales of modern traditional Chinese medicines. The modern factory was built with an investment of 0.6 billion yuan and is located in the Shanghai Comprehensive Industrial Development Zone. Listed on the Shenzhen Stock Exchange in 2010, it is one of the first GEM listed companies in Fengxian District. The company is mainly engaged in R&D, production and sales of modern traditional Chinese medicine. The company's main products are phlegm removal series products. Corporate honors: National Comprehensive Assessment of Quality Trustworthy Products - Gureqing; Traditional Chinese Medicine Protected Variety Certificate - Gureqing; 2014 National Quality and Integrity Double Pharmaceutical Enterprise; 2nd China Health Reform Enterprise Support List 2014 Most Socially Influential Enterprise; 2nd China Health Reform Enterprise Support List 2014 Most Socially Influential Enterprise Certificate; 2013 China Model Enterprise of Integrity; 2013 China Model Enterprise of Integrity; 2013 China Model Credit Enterprise Certificate; China Pharmaceutical Daily Executive Director Unit; 2013 Top 20 Most Competitive Pharmaceutical Listed Companies; “2022 Industry Pioneer Award” “National Intellectual Property Advantage” “Companies”, “2022 China's Top 100 Traditional Chinese Medicine Companies,” “2023 Shanghai Top 100 Emerging Industry Enterprises,” and “2023 Shanghai Top 100 Private Manufacturing Enterprises”, etc.